###begin article-title 0
Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing
###end article-title 0
###begin p 1
H.C. Chong and M.J. Tan contributed equally to this paper.
###end p 1
###begin p 2
###xml 818 823 <span type="species:ncbi:9606">human</span>
Skin morphogenesis, maintenance, and healing after wounding require complex epithelial-mesenchymal interactions. In this study, we show that for skin homeostasis, interleukin-1 (IL-1) produced by keratinocytes activates peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) expression in underlying fibroblasts, which in turn inhibits the mitotic activity of keratinocytes via inhibition of the IL-1 signaling pathway. In fact, PPARbeta/delta stimulates production of the secreted IL-1 receptor antagonist, which leads to an autocrine decrease in IL-1 signaling pathways and consequently decreases production of secreted mitogenic factors by the fibroblasts. This fibroblast PPARbeta/delta regulation of the IL-1 signaling is required for proper wound healing and can regulate tumor as well as normal human keratinocyte cell proliferation. Together, these findings provide evidence for a novel homeostatic control of keratinocyte proliferation and differentiation mediated via PPARbeta/delta regulation in dermal fibroblasts of IL-1 signaling. Given the ubiquitous expression of PPARbeta/delta, other epithelial-mesenchymal interactions may also be regulated in a similar manner.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 953 966 953 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Fusenig, 1994</xref>
Adult epidermis is a stratified epithelium in which keratinocytes from the basal and suprabasal layers cease to divide concomitantly with their outward movement and terminal differentiation all through enucleation and keratinization. After injury, the restoration of its functional integrity is of utmost importance to the survival of the organism. The maintenance of epithelium and its regeneration to close the wound is orchestrated with the contribution of the underlying dermal tissue. This synchrony is key to preventing either insufficient or excess wound repair. The regulation of wound repair is dictated by epithelial-mesenchymal interactions and purportedly mediated by the action of central players such as growth factors. This complex interplay demands the expression of soluble factors exerting autocrine and paracrine activities and, importantly, the integration of such diverse signals, which culminate in appropriate cellular responses (Fusenig, 1994). Although the importance of the epithelial-mesenchymal communication is well recognized, the mechanism underlying this process needs in-depth study.
###end p 4
###begin p 5
###xml 198 212 198 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Schroder, 1995</xref>
###xml 309 327 302 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Arend et al., 1998</xref>
###xml 1219 1242 1184 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Rauschmayr et al., 1997</xref>
###xml 220 225 <span type="species:ncbi:9606">human</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
Of the numerous cytokines produced by skin cells, interleukin-1 (IL-1) has a pronounced influence on skin homeostasis and wound repair, and there are multiple mechanisms to regulate IL-1 signaling (Schroder, 1995). Both human and mouse keratinocytes constitutively produce biologically active IL-1alpha/beta (Arend et al., 1998). The two distinct forms of IL-1, termed IL-1alpha and IL-1beta, are capable of binding to the same receptor with similar affinities to trigger biological effects. For any cells to respond productively to IL-1alpha/beta, they must possess corresponding cell surface receptors. Two distinct IL-1 receptors (IL-1Rs) have been cloned and characterized. The type I IL-1R (IL-1R1) mediates all known responses of IL-1. In contrast, the type 2 IL-1R (IL-1R2) is incapable of participating in signal transduction by virtue of its short cytoplasmic tail and thus is thought to neutralize the action of the bound IL-1alpha/beta. Interestingly, the predominant IL-1R species expressed by keratinocytes, both constitutively and after activation of the cells, is the IL-1R2. Its production by keratinocytes would represent an efficient mean for these cells to escape autocrine IL-1alpha/beta signaling (Rauschmayr et al., 1997). In contrast, the dermal fibroblasts express mainly the IL-1R1 isotype and thus are very sensitive to IL-1alpha/beta signaling.
###end p 5
###begin p 6
###xml 701 719 680 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Banda et al., 2005</xref>
###xml 858 876 837 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Arend et al., 1998</xref>
The effects of IL-1alpha/beta on target cells can also be inhibited via the binding of the IL-1R antagonist (IL-1ra) to IL-1R1. There are two structural variants of IL-1ra, secreted IL-1ra (sIL-1ra) and intracellular IL-1ra (icIL-1ra). Both isoforms are transcribed from the same gene via two different promoters and alternative first exons. IL-1ra binds to IL-1R1 with an affinity that is 100-500 times higher than for IL-1R2 and competitively inhibits IL-1alpha/beta binding to the receptor. Although icIL-ra may be released from keratinocytes under some conditions to compete for receptor binding, it can inhibit IL-1alpha/beta-induced cytokine production intracellularly via the COP9 signalosome (Banda et al., 2005). Fibroblasts produce both IL-1ra isoforms when appropriately stimulated, whereas keratinocytes only constitutively produce the icIL-1ra (Arend et al., 1998).
###end p 6
###begin p 7
###xml 156 176 156 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Kersten et al., 2000</xref>
###xml 300 346 285 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Nuclear Receptors Nomenclature Committee, 1999</xref>
###xml 657 673 635 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Tan et al., 2001</xref>
###xml 675 695 653 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Burdick et al., 2006</xref>
###xml 1010 1026 970 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Tan et al., 2001</xref>
###xml 1028 1047 988 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Di Poi et al., 2002</xref>
###xml 1261 1280 1221 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Peters et al., 2000</xref>
###xml 1282 1303 1242 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Michalik et al., 2001</xref>
###xml 1435 1456 1388 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Michalik et al., 2001</xref>
###xml 1458 1474 1411 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Kim et al., 2005</xref>
###xml 1476 1492 1429 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Man et al., 2008</xref>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 1096 1100 <span type="species:ncbi:10090">mice</span>
###xml 1476 1479 <span type="species:ncbi:9606">Man</span>
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors involved in the control of chronic diseases such as diabetes and obesity (Kersten et al., 2000). The PPAR subgroup comprises three related members named PPARalpha (NR1C1), PPARbeta/delta (NR1C2), and PPARgamma (NR1C3; Nuclear Receptors Nomenclature Committee, 1999). Ligand-activated PPARs form obligate heterodimers with the retinoid X receptor and bind to defined peroxisome proliferator response elements (PPREs) in the regulatory regions of target genes. Several works have shown that ligand-activated PPARbeta/delta can induce terminal differentiation of keratinocytes (Tan et al., 2001; Burdick et al., 2006). Other studies comparing PPARbeta/delta-null (KO) with wild-type (WT) mice showed that inflammatory signals increase the expression and activity of PPARbeta/delta, which confer a pronounced antiapoptotic capacity to the keratinocytes, mediated in part via the increased activity of the PKBalpha survival pathway (Tan et al., 2001; Di Poi et al., 2002). Nonetheless, it is paradoxical that in the KO mice, epidermal hyperproliferation was observed either in early wound repair, upon hair plucking, or in response to a topical challenge with the phorbol ester (TPA; Peters et al., 2000; Michalik et al., 2001). Thus, the role of PPARbeta/delta on cell proliferation remains debatable, and its mechanism of action is not sufficiently known (Michalik et al., 2001; Kim et al., 2005; Man et al., 2008).
###end p 7
###begin p 8
Herein, we provide evidence for a novel paracrine effect of PPARbeta/delta on epithelial cell growth. We found that PPARbeta/delta in the fibroblasts attenuates keratinocyte proliferation by directly increasing the expression of sIL-1ra, thereby repressing IL-1 signaling. Epithelial-mesenchymal communications and IL-1 signaling are responsible for a wide range of biological events such as wound repair and tumorigenesis. Our results underscore the paracrine role of PPARbeta/delta in the control of cell proliferation involving epithelial-mesenchymal interactions.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
PPARbeta/delta knockdown in dermal fibroblasts results in increased keratinocyte proliferation
###end title 10
###begin p 11
###xml 138 154 131 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Tan et al., 2001</xref>
###xml 156 176 149 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Schmuth et al., 2004</xref>
###xml 771 779 742 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 1080 1088 1030 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1198 1206 1141 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 276 281 <span type="species:ncbi:9606">human</span>
###xml 856 861 <span type="species:ncbi:9606">human</span>
Earlier studies have shown that ligand-activated PPARbeta/delta induced the differentiation of human keratinocytes in monolayer cultures (Tan et al., 2001; Schmuth et al., 2004). Herein, we examined the autocrine and paracrine consequences of PPARbeta/delta deficiency during human epidermis formation using the organotypic skin culture (OTC) model. We first examined the expression pattern of the three PPAR isotypes in fibroblasts and keratinocytes of control OTC. Both quantitative real-time PCR (qPCR) and ELISA analyses performed on mechanically separated dermis and epidermis equivalents of OTCs revealed that PPARbeta/delta is the predominant isotype in the keratinocytes and dermal fibroblasts, whereas the lower levels of PPARalpha and PPARgamma are comparable (Fig. 1 A). We next assessed the knockdown efficiency of PPARbeta/delta expression in human keratinocytes and fibroblasts by lentivirus-mediated siRNAs using qPCR and immunoblot analyses. qPCR revealed a >95% reduction of PPARbeta/delta expression in cells transduced with the siRNA PPARbeta/delta11 sequence (Fig. 1 B, left). Immunoblot analysis also showed negligible levels of PPARbeta/delta protein in the transduced cells (Fig. 1 B, right). These cells were used for subsequent experiments.
###end p 11
###begin p 12
###xml 0 70 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;-deficient fibroblasts increase epidermal proliferation.</bold>
###xml 686 690 651 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 686 690 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 695 709 660 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 695 709 660 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 715 719 673 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 715 719 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 724 738 682 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 724 738 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1165 1166 1111 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 436 441 <span type="species:ncbi:9606">Human</span>
PPARbeta/delta-deficient fibroblasts increase epidermal proliferation. (A) Expression profile of PPARs in OTC keratinocytes and fibroblasts. Total RNA and protein were extracted from keratinocytes and fibroblasts in OTC. Expression levels of PPAR mRNA (left) and protein (right) were monitored by qPCR and PPAR transcription factor assay kit, respectively. PPARbeta/delta mRNA was normalized with control ribosomal protein P0 mRNA. (B) Human keratinocytes or fibroblasts were transduced with a lentiviral vector harboring a control or two different PPARbeta/delta (PPARbeta/delta9 and PPARbeta/delta11) siRNAs. (C) Immunoblot analysis of epidermis from 2-wk-old OTCs constructed using KCTRL or KPPARbeta/delta and FCTRL or FPPARbeta/delta. Involucrin and transglutaminase I (Tgase I) are terminal differentiation markers, and keratin 10 (CK10) is an early differentiation marker. Keratin 5 (CK5) identifies the basal keratinocytes. Cell proliferation was measured using PCNA and cyclin D1. Apoptosis was detected using caspase 3. beta-Tubulin showed equal loading and transfer. Representative immunoblots of epidermis from two OTCs are shown. Data are mean +/- SD, n = 3.
###end p 12
###begin p 13
###xml 60 64 60 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 108 122 101 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 108 122 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 147 151 133 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 147 151 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 197 211 176 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 197 211 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 307 311 279 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 307 311 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 313 317 285 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 313 317 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 419 427 391 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 446 460 418 425 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 446 460 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 588 596 546 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 610 630 568 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Schmuth et al., 2004</xref>
###xml 756 764 714 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 907 921 858 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 907 921 858 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1067 1075 1011 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1161 1175 1105 1112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1161 1175 1105 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1177 1191 1114 1121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1177 1191 1114 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1312 1326 1242 1249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1312 1326 1242 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1328 1336 1251 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1374 1388 1297 1304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1374 1388 1297 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1511 1515 1427 1431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1511 1515 1427 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1517 1525 1433 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1649 1667 1565 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Smola et al., 1998</xref>
###xml 1722 1736 1638 1645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1722 1736 1638 1645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1741 1755 1650 1657 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1741 1755 1650 1657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1906 1925 1808 1827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Peters et al., 2000</xref>
###xml 1927 1948 1829 1850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Michalik et al., 2001</xref>
###xml 2009 2023 1911 1918 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 2009 2023 1911 1918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1900 1904 <span type="species:ncbi:10090">mice</span>
Next, OTCs were reconstructed using control keratinocytes (KCTRL), PPARbeta/delta knockdown keratinocytes (KPPARbeta/delta), control fibroblasts (FCTRL), and PPARbeta/delta knockdown fibroblasts (FPPARbeta/delta) in various combinations. Immunoblot analysis and immunofluorescence staining of the 2-wk-old KCTRL/FCTRL OTCs showed the expected keratinocyte differentiation markers keratin 5, keratin 10, and involucrin (Fig. 1 C and ). OTCs with KPPARbeta/delta showed a reduced expression of terminal markers, which is consistent with the known prodifferentiation role of PPARbeta/delta (Fig. 1 C and Fig. S1; Schmuth et al., 2004). No difference in keratin 5 expression, localized to the basal layer of the epidermis, was observed among the various OTCs (Fig. 1 C and Fig. S1). This provided evidence for a cell-autonomous action of PPARbeta/delta in keratinocyte differentiation. Interestingly, OTC with FPPARbeta/delta led to increased keratinocyte proliferation as indicated by an increase in expression of cyclin D1 and proliferating cell nuclear antigen (PCNA; Fig. 1 C) and in Ki67-positive cells with respect to the control OTC (Fig. S1). Notably, the KPPARbeta/delta/FPPARbeta/delta OTC similarly displayed this enhanced proliferation of keratinocytes regardless of the impaired differentiation of the KPPARbeta/delta (Fig. 1 C and Fig. S1). Furthermore, OTC with KPPARbeta/delta showed threefold more apoptotic cells (TUNEL positive) and a higher level of cleaved caspase 3 as compared with OTC with KCTRL (Fig. 1 C and Fig. S1). A dynamic epithelial-mesenchymal interaction is essential for the proper formation of the basement membrane (Smola et al., 1998). The reduced laminin 5 staining in OTCs with either KPPARbeta/delta or FPPARbeta/delta suggested a dysregulated epithelial-mesenchymal communication (Fig. S1). Altogether, these results are consistent with the observations from KO mice (Peters et al., 2000; Michalik et al., 2001) and revealed a potent proliferation stimulatory effect of FPPARbeta/delta on cocultured keratinocytes, providing evidence for an important noncell autonomous PPARbeta/delta-dependent mechanism regulating keratinocyte proliferation.
###end p 13
###begin title 14
###xml 27 41 27 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 27 41 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
Organotypic cultures with FPPARbeta/delta show increased expression of mitogenic factors
###end title 14
###begin p 15
###xml 25 39 25 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 25 39 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 261 275 254 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 261 275 254 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 464 468 450 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 464 468 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 473 487 459 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 473 487 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 658 672 637 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 658 672 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 674 681 646 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 1090 1104 1055 1062 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1090 1104 1055 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1125 1129 1083 1087 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1125 1129 1083 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
The paracrine effect of FPPARbeta/delta on epidermal proliferation is likely mediated by changes in the secretion of mitogenic or antimitogenic factors by the fibroblasts. To understand the mechanism underlying the enhanced epidermal proliferation in OTC with FPPARbeta/delta, an unbiased protein array was performed. Inflammatory cytokine and growth factor arrays were used to compare conditioned media from OTCs reconstructed using WT keratinocytes with either FCTRL or FPPARbeta/delta. A total of 76 distinct proteins were screened, and the results showed that the protein expression of several mitogenic factors and cytokines were increased in OTC with FPPARbeta/delta (Table I). Notably, most of the proteins whose expression was increased have a known mitogenic action on keratinocytes. The expression of TGF-beta1, which exerts an antiproliferative effect on keratinocytes, and the abundant IL-1alpha, constitutively produced by keratinocytes, remained unchanged. The expression of two proangiogenic factors, namely VEGF and placental growth factor (PIGF), were reduced in OTC with FPPARbeta/delta when compared with FCTRL.
###end p 15
###begin p 16
###xml 57 71 57 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 57 71 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 87 91 80 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 87 91 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
Relative fold change of protein expression in OTCs with FPPARbeta/delta compared with FCTRL
###end p 16
###begin p 17
###xml 210 214 210 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 216 220 216 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 335 336 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
The intensities of signals were quantified by densitometry. Positive control included in the array blot was used to normalize and compare the results from different membranes. Values obtained from the control KCTRL/FCTRL OTC were arbitrarily assigned a value of 1. Values represent the mean fold increase as compared with control OTC (n = 3).
###end p 17
###begin p 18
mRNA expression levels of these genes were further verified by qPCR.
###end p 18
###begin p 19
P < 0.01.
###end p 19
###begin p 20
P < 0.1.
###end p 20
###begin p 21
###xml 180 184 173 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 180 184 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 190 204 183 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 190 204 183 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 316 320 295 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 316 320 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 402 410 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 427 441 406 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 427 441 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 652 660 617 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
To verify that a reduced PPARbeta/delta expression leads to a transcriptional up-regulation of mitogenic factor expression, we performed qPCR on selected mitogenic genes from OTC FCTRL and FPPARbeta/delta in the absence or presence of the PPARbeta/delta agonist GW501516. Consistent with the protein array results, FCTRL exposed to GW501516 for 12 h showed a decrease in the expression of these genes (Fig. 2 A). Importantly, FPPARbeta/delta expressed higher basal levels of these mitogenic factors and, as expected, ligand treatment had no effect. Altogether, fibroblasts deficient in PPARbeta/delta have an increased expression of mitogenic factors (Fig. 2 A).
###end p 21
###begin p 22
###xml 0 143 0 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reduced fibroblast PPAR&#946;/&#948; expression increases IL-1&#946; activation of TAK1 and up-regulation of AP-1&#8211;controlled mitogenic target genes.</bold>
###xml 202 216 192 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 202 216 192 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 222 226 205 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 222 226 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 493 497 469 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 493 497 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 553 567 529 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 553 567 529 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 573 577 542 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 573 577 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 594 598 563 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 594 598 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 600 614 569 576 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 600 614 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 620 624 582 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 620 624 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 626 630 588 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 626 630 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 637 638 599 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 839 843 794 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 839 843 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 848 862 803 810 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 848 862 803 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1288 1289 1222 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1348 1352 1282 1286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1348 1352 1282 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1423 1424 1355 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Reduced fibroblast PPARbeta/delta expression increases IL-1beta activation of TAK1 and up-regulation of AP-1-controlled mitogenic target genes. (A) Expression of mitogenic factor mRNAs in 2-wk old OTC FPPARbeta/delta and FCTRL treated with PPARbeta/delta agonist (500 nM GW501516 for 24 h) or vehicle. The expression levels of the indicated mitogenic factors were analyzed by qPCR and normalized to control ribosomal protein P0. Results are represented in fold induction as compared with OTC FCTRL. (B) Immunoblot analysis of phosphorylated c-Jun from FPPARbeta/delta and FCTRL extracted from KCTRL/FPPARbeta/delta and KCTRL/FCTRL OTCs (n = 2), respectively. Total c-Jun and TAK1 protein expression level, which remains unchanged, showed equal loading and transfer. (C) Immunoblot analysis of IL-1beta and TNF-alpha activation of TAK1 in FCTRL or FPPARbeta/delta. Cells were treated with either vehicle (DMSO) or 800 nM GW501516 for 24 h prior to exposure to 10 ng/ml IL-1beta (top) or TNF-alpha (bottom). At the indicated time points, total cell lysates were extracted. Equal amounts of total protein (50 microg) were resolved, electrotransferred, and probed for phosphorylated TAK1 (Thr184/187), total TAK1, and beta-tubulin. Values below each band represent the mean fold differences (n = 3) in expression level with respect to vehicle-treated FCTRL at 5 min, which was assigned the value of one. Data are mean +/- SEM, n = 3.
###end p 22
###begin title 23
###xml 46 60 46 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 46 60 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
Increased expression of mitogenic factors by FPPARbeta/delta results from attenuated IL-1beta/TAK1/AP-1 activation
###end title 23
###begin p 24
###xml 123 137 123 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 123 137 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 258 280 251 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Szabowski et al., 2000</xref>
###xml 282 301 275 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Florin et al., 2004</xref>
###xml 426 447 419 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Watanabe et al., 2002</xref>
###xml 449 468 442 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Heiman et al., 2005</xref>
###xml 556 575 549 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Wiener et al., 2008</xref>
###xml 724 738 710 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 724 738 710 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 803 817 782 789 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 803 817 782 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 823 827 795 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 823 827 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 856 860 828 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 856 860 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 862 876 834 841 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 862 876 834 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 882 886 847 851 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 882 886 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 888 892 853 857 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 888 892 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 946 960 911 918 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 946 960 911 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 980 984 938 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 980 984 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 986 1000 944 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 986 1000 944 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1109 1117 1060 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
Next, we sought to identify the signaling cascade that culminates in the up-regulation of the mitogenic growth factors in FPPARbeta/delta. The expression of most of these genes is known to be regulated by the transcription factor activation protein-1 (AP-1; Szabowski et al., 2000; Florin et al., 2004). Although direct regulation of eotaxin-2 by AP-1 has not been reported, the expression of this gene is stimulated by IL-1 (Watanabe et al., 2002; Heiman et al., 2005). The increased expression of I-309 is likely the consequence of increased IL-8 level (Wiener et al., 2008). We first addressed the hypothesis that AP-1 belongs to the pathway through which PPARbeta/delta regulates the expression of mitogenic factors in FPPARbeta/delta. We examined the levels of phosphorylated (activated) c-Jun in FPPARbeta/delta and FCTRL fibroblasts extracted from KCTRL/FPPARbeta/delta and KCTRL/FCTRL OTCs, respectively. Immunoblot analysis showed that FPPARbeta/delta isolated from the KCTRL/FPPARbeta/delta OTCs had enhanced phosphorylated c-Jun, which is consistent with an increased activity of the AP-1 complex (Fig. 2 B) and increased production of growth factors.
###end p 24
###begin p 25
###xml 156 175 156 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Florin et al., 2004</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">2005</xref>
###xml 281 298 270 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Shim et al., 2005</xref>
###xml 419 423 401 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 419 423 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 429 443 411 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 429 443 411 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 488 492 456 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 488 492 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 498 512 466 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 498 512 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 724 728 671 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 724 728 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 770 778 710 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 929 937 866 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 953 967 890 897 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 953 967 890 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1105 1109 1035 1039 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1105 1109 1035 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1139 1147 1062 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 1300 1308 1205 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 1572 1576 1477 1481 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1572 1576 1477 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1578 1582 1483 1487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1578 1582 1483 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1588 1592 1493 1497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1588 1592 1493 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1594 1608 1499 1506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1594 1608 1499 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1691 1705 1589 1596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1691 1705 1589 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1726 1730 1617 1621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1726 1730 1617 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1812 1826 1703 1710 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1812 1826 1703 1710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
The TGF-activated kinase 1 (TAK1) plays a pivotal role in the activation of many genes, including genes encoding mitogenic factors, via activation of AP-1 (Florin et al., 2004, 2005). The IL-1alpha/beta released by keratinocytes and TNF-alpha present in wound sites activate TAK1 (Shim et al., 2005). To investigate the effect of PPARbeta/delta on TAK1 activation, we examined the expression of phosphorylated TAK1 in FCTRL and FPPARbeta/delta after IL-1beta and TNF-alpha stimulations. FCTRL and FPPARbeta/delta were treated with either vehicle (DMSO) or PPARbeta/delta agonist (GW501516) for 24 h prior to stimulation by either IL-1beta or TNF-alpha. As expected, there was an increase in phospho-TAK1 in vehicle-treated FCTRL exposed to either IL-1beta or TNF-alpha (Fig. 2 C). Cotreatment of these fibroblasts with IL-1beta and GW501516 significantly prevented the increase in phospho-TAK1 levels in a dose-dependent manner (Fig. 2 C and ). In the FPPARbeta/delta, a more robust increase in phospho-TAK1 was observed, which was only marginally affected by GW501516, showing that the ligand effect in FCTRL was PPARbeta/delta specific (Fig. 2 C and Fig. S2 A). In contrast, neither ligand-activated PPARbeta/delta nor PPARbeta/delta deficiency had an effect on TNF-alpha-mediated TAK1 activation (Fig. 2 C and Fig. S2 A). To further this observation, we performed chromatin immunoprecipitation (ChIP) using phospho-c-Jun antibodies on the keratinocyte growth factor (KGF) and granulocyte macrophage colony-stimulating factor (GMCSF) gene promoters in fibroblasts from KCTRL/FCTRL and KCTRL/FPPARbeta/delta OTCs (Fig. S2 B). There was more phospho-c-Jun immunoprecipitated chromatin from FPPARbeta/delta when compared with FCTRL, pointing to enhanced AP-1 binding and activation of the KGF and GMCSF genes in FPPARbeta/delta (Fig. S2 B). Together, these results indicate that PPARbeta/delta specifically attenuates IL-1beta-mediated TAK1 activation and thus AP-1 activity.
###end p 25
###begin title 26
###xml 78 92 71 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 78 92 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
Neutralization of IL-1alpha/beta signaling abolishes the mitogenic action of FPPARbeta/delta
###end title 26
###begin p 27
###xml 155 169 148 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 155 169 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 472 486 423 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 472 486 423 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 634 648 571 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 634 648 571 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 875 881 798 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 1489 1504 1405 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, B and C</xref>
###xml 1601 1615 1517 1524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1601 1615 1517 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
Our results showed that IL-1beta-mediated but not TNF-alpha-mediated TAK1 activation and AP-1-dependent expression of mitogenic factors were increased in FPPARbeta/delta. This result suggested that the IL-1alpha/beta pathway is responsible for the mitogenic effect of PPARbeta/delta knockdown in fibroblasts. Conceivably, negating the effect of IL-1alpha/beta with neutralizing antibodies against IL-1alpha/beta would counteract the effect of PPARbeta/delta knockdown in FPPARbeta/delta. As anticipated, OTCs exposed to anti-IL-1alpha/beta antibodies displayed a reduction in Ki67-positive keratinocytes, and the mitogenic action of FPPARbeta/delta was completely abolished (, compare A with C), indicating that IL-1alpha/beta signaling is a major pathway in the control of keratinocyte proliferation. This was further confirmed by immunoblot analysis of cyclin D1 and PCNA (Fig. 3, compare A with C). Similarly, inhibiting the action of the mitogenic factors should replicate the neutralizing effect of anti-IL-1alpha/beta antibodies. To test this possibility, we treated the OTCs with neutralizing antibodies against KGF, GMCSF, and IL-6, which are the three most abundant mitogenic factors in our model. To avoid possible compensatory effects, we neutralized all three growth factors simultaneously. Consistent with the aforementioned results, all OTCs showed thinner epidermis and reduced keratinocyte proliferation when compared with the corresponding OTC treated with preimmune IgG (Fig. 3, B and C and Fig. S3, B and C). Altogether, our observations indicated that the mitogenic action of the FPPARbeta/delta was caused by an increase in IL-1alpha/beta-mediated expression of mitogenic factors via TAK1 and AP-1.
###end p 27
###begin p 28
###xml 106 120 99 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 106 120 99 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 0 121 0 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neutralizing antibodies against IL-1&#945;/&#946; or KGF, GMCSF, and IL-6 abolished the mitogenic effect of F<italic><sub>PPAR&#946;/&#948;</sub></italic>.</bold>
###xml 541 545 520 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 541 545 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 552 556 531 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 552 556 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 558 562 537 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 558 562 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
Neutralizing antibodies against IL-1alpha/beta or KGF, GMCSF, and IL-6 abolished the mitogenic effect of FPPARbeta/delta. (A-C) Immunoblot analysis of epidermis from indicated OTCs treated with 400 ng/ml IL-1alpha/beta (A), KGF, GMCSF, and IL-6 (B) neutralizing antibodies (each at 400 ng/ml) or 400 ng/ml preimmune IgG (C). Antibodies were added to OTC medium at each change of medium. Cell proliferation was measured using cyclin D1 and PCNA. Values below each band represent the mean fold differences in expression level with respect to KCTRL from KCTRL/FCTRL OTC, which was assigned the value of 1. beta-Tubulin served as a loading control. Representative immunoblots of epidermis from two indicated OTCs are shown.
###end p 28
###begin title 29
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human sIL-1ra gene is a direct target of PPARbeta/delta in fibroblasts
###end title 29
###begin p 30
###xml 147 166 140 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Groves et al., 1996</xref>
###xml 168 195 161 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Maas-Szabowski et al., 2000</xref>
###xml 292 299 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 818 822 763 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 818 822 763 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 828 842 773 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 828 842 773 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 869 873 807 811 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRTL</sub>
###xml 869 873 807 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CRTL</sub></italic>
###xml 879 893 817 824 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 879 893 817 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 956 960 887 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRTL</sub>
###xml 956 960 887 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CRTL</sub></italic>
###xml 1054 1062 978 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 1153 1157 1077 1081 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1153 1157 1077 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1176 1190 1100 1107 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1176 1190 1100 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1267 1275 1184 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
In vivo, the release of IL-1alpha/beta by basal keratinocytes is sufficient to maintain tissue homeostasis and to initiate cutaneous inflammation (Groves et al., 1996; Maas-Szabowski et al., 2000). Although we did not detect a change in the expression of IL-1alpha/beta in the protein array (Table I), we clearly showed that PPARbeta/delta specifically attenuated IL-1beta response, including the activation of TAK1. This suggested that the attenuation of IL-1beta signaling by PPARbeta/delta occurs upstream of TAK1 activation. To examine whether PPARbeta/delta has a regulatory effect in IL-1alpha/beta signaling cascade, we measured the mRNA levels of IL-1alpha, IL-1beta, IL-1R1, IL-1R2, icIL-1ra, sIL-1ra, and IL-1R-associated kinase, which are all key players of IL-1 signaling, in OTC epidermal keratinocytes (KCTRL and KPPARbeta/delta) and dermal fibroblasts (FCRTL and FPPARbeta/delta). With the exception of a higher level of sIL-1ra in the OTC FCRTL, we detected no change in the expression of the other mediators of IL-1alpha/beta signaling (Fig. 4 A and not depicted). Consistently, elevated sIL-1ra was detected in the medium of OTC with FCTRL as compared with FPPARbeta/delta, but no difference was observed in icIL-1ra protein within the fibroblasts (Fig. 4 A).
###end p 30
###begin p 31
###xml 0 79 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Human sIL-1ra is encoded in a direct PPAR&#946;/&#948; target gene in fibroblasts.</bold>
###xml 174 178 167 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 174 178 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 184 198 177 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 184 198 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 218 222 204 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRTL</sub>
###xml 218 222 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CRTL</sub></italic>
###xml 228 242 214 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 228 242 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 391 395 370 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 391 395 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 397 401 376 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 397 401 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 407 411 386 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 407 411 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 413 427 392 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 413 427 392 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1787 1791 1721 1725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1787 1791 1721 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1802 1816 1736 1743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1802 1816 1736 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 2108 2109 2033 2034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 523 528 <span type="species:ncbi:9606">human</span>
###xml 656 661 <span type="species:ncbi:9606">human</span>
###xml 1123 1128 <span type="species:ncbi:9606">human</span>
###xml 1659 1664 <span type="species:ncbi:9606">human</span>
Human sIL-1ra is encoded in a direct PPARbeta/delta target gene in fibroblasts. (A) Expression of sIL-1ra and icIL-1ra mRNA (left) and protein (right) in OTC keratinocytes (KCTRL and KPPARbeta/delta) and fibroblasts (FCRTL and FPPARbeta/delta). sIL-1ra and icIL-1ra mRNA were analyzed by qPCR and normalized to ribosomal protein P0. The sIL-1ra level was determined by ELISA from medium of KCTRL/FCTRL and KCTRL/FPPARbeta/delta OTCs. The icIL-1ra levels were measured by ELISA from cell lysates. (B) PPRE1 and PPRE3 of the human sIL-1ra gene are functional. Transactivation assay in fibroblasts cotransfected with a luciferase (luc) promoter driven by the human sIL-1ra promoter and pEF1-beta-galactosidase as control of transfection efficiency. Relative positions of the three putative PPREs (PPRE 1-3) and their mutants (mPPRE 1-3) are represented in closed and open ovals, respectively. Cells were treated with either 500 nM GW501516 (GW) and/or 10 ng/ml IL-1beta for 24 h. Luciferase activity was measured, and normalized reporter activity is shown as fold induction as compared with untreated fibroblasts. (C) EMSA of human sIL-1ra PPRE1 and PPRE3. Radiolabeled PPRE1 (left) and PPRE3 (middle) were incubated either with RXRalpha, PPARbeta/delta, or both. NSC denotes nonspecific competitor, the nonfunctional MEd DR1 element in the malic enzyme promoter. SC denotes nonradiolabeled consensus PPRE (conPPRE). As positive control, conPPRE was used. Mutated consensus PPRE is denoted by mconPPRE. PPARbeta/delta did not bind to PPRE2 and mutated PPRE probes (mconPPRE, mPPRE1, mPPRE2, and mPPRE3; right). (D) PPARbeta/delta binds to PPRE1 and PPRE3 of the human sIL-1ra gene in fibroblasts. ChIP assays were conducted using preimmune IgG or antibodies against PPARbeta/delta (AB) in FCTRL (WT) and FPPARbeta/delta (kd) fibroblasts extracted from two independent OTCs (OTC1 and OTC2). The regions spanning PPRE1 and PPRE2 of the sIL-1ra gene were amplified using appropriate primers (). A control region between PPRE1 and PPRE2 served as negative control. *, P < 0.05; **, P < 0.01. Data are mean +/- SEM, n = 4.
###end p 31
###begin p 32
###xml 426 447 419 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Podvinec et al., 2002</xref>
###xml 612 620 598 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 760 778 731 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Smith et al., 1994</xref>
###xml 907 915 863 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1531 1539 1473 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1834 1856 1776 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">IJpenberg et al., 2004</xref>
###xml 1893 1897 1835 1839 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1893 1897 1835 1839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 2008 2016 1936 1944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 2052 2066 1980 1987 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 2052 2066 1980 1987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 2351 2355 2265 2269 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 2351 2355 2265 2269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 2320 2325 <span type="species:ncbi:9606">human</span>
###xml 2381 2386 <span type="species:ncbi:9606">human</span>
###xml 2449 2454 <span type="species:ncbi:9606">human</span>
To determine whether the sIL-1ra promoter is directly regulated by PPARbeta/delta in the fibroblasts, a 4.4-kb fragment of the promoter region was subcloned into a luciferase reporter vector and analyzed in transactivation assays. Three putative PPRE sequences were identified in the sIL-1ra promoter (GenBank no. X64532), PPRE1 at position -1,038/-1,050, PPRE2 at -1,072/-1,084, and PPRE3 at -4,067/-4,079, using NUBIScan (; Podvinec et al., 2002). Transfected primary fibroblasts treated with the PPARbeta/delta ligand GW501516 alone showed only a modest approximately threefold increase in reporter activity (Fig. 4 B). As expected, treatment with IL-1beta increased the reporter activity by approximately20-fold, which is consistent with an earlier study (Smith et al., 1994). Importantly, this IL-1beta-mediated transactivation was further enhanced by treatment with GW501516 (to approximately50-fold; Fig. 4 B). To identify the functional PPREs responsible for the PPAR-mediated up-regulation, site-directed mutagenesis of the PPREs was performed. Transactivation assays with the various mutated promoters clearly showed that the stimulatory effects of PPARbeta/delta were mediated by two PPREs, i.e., PPRE1 and PPRE3. To investigate whether PPARbeta/delta was truly bound to these identified PPREs, electrophoretic mobility shift assay (EMSA) and ChIP were performed. As expected, specific protein-DNA complexes were detected in EMSA for PPRE1 and PPRE3, which were effectively competed by a consensus PPRE oligonucleotide (Fig. 4 C). As a positive control, the consensus PPRE oligonucleotide was used as a probe, which was specifically competed by the unlabeled consensus PPRE but not by a nonspecific competitor containing a nonfunctional MEd (malic enzyme distal PPRE) DR1 element from the malic enzyme promoter (Fig. S4 B; IJpenberg et al., 2004). Similarly, ChIP performed on OTC FCTRL using a monoclonal anti-PPARbeta/delta antibody showed the binding of PPARbeta/delta to both PPRE1 and PPRE3 (Fig. 4 D). This effect was not observed in FPPARbeta/delta, and no signal was seen with preimmune serum either. In addition, no binding was detected to a control sequence residing between PPRE1 and PPRE3. These data clearly showed that PPARbeta/delta specifically binds to the identified functional PPREs in the human sIL-1ra promoter in OTC FCTRL. They indicated that the human sIL-1ra promoter is a direct PPARbeta/delta target in primary human dermal fibroblasts.
###end p 32
###begin p 33
Altogether, we showed that IL-1alpha/beta secreted by the keratinocytes activates TAK1/AP-1 signaling, which up-regulates the expression of mitogenic factors in the fibroblasts and thus enhances epidermal proliferation. We also showed that PPARbeta/delta in the fibroblasts plays a homeostatic role in which it stimulates the expression of the sIL-1ra, modulates IL-1alpha/beta-mediated mitogenic factors gene expression, and thus attenuates epidermal proliferation.
###end p 33
###begin title 34
sIL-1ra knockdown fibroblasts increase keratinocyte proliferation
###end title 34
###begin p 35
###xml 229 243 215 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 229 243 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 367 381 346 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 367 381 346 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 448 462 420 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 448 462 420 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 579 587 544 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
We showed that the sIL-1ra gene in fibroblasts is a direct target of PPARbeta/delta and that accordingly, PPARbeta/delta knockdown results in a reduced production of sIL-1ra. To test whether the reduced production of sIL-1ra by FPPARbeta/delta triggers keratinocyte proliferation, we examined the effect of exogenous IL-1ra supplemented into the medium of OTCs with FPPARbeta/delta. Importantly, exogenous IL-1ra abolished the mitogenic effect of FPPARbeta/delta (). This was further confirmed by immunoblot analysis of cyclin D1 and PCNA on the epidermis from the various OTCs (Fig. 5 A). Thus, inhibition of IL-1alpha/beta signaling using IL-1ra can rescue the pro-proliferating effect that PPARbeta/delta deficiency in the fibroblasts has on keratinocyte proliferation.
###end p 35
###begin p 36
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reduced sIL-1ra in fibroblasts potentiates epidermal keratinocyte proliferation.</bold>
###xml 312 320 312 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 732 736 732 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 759 763 759 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 759 763 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 788 795 788 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 788 795 788 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 1403 1407 1391 1395 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1403 1407 1391 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1412 1416 1400 1404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1412 1416 1400 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1433 1437 1421 1425 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1433 1437 1421 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1439 1443 1427 1431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 1439 1443 1427 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 1501 1502 1487 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 359 364 <span type="species:ncbi:9606">human</span>
Reduced sIL-1ra in fibroblasts potentiates epidermal keratinocyte proliferation. (A) Immunoblot analysis of epidermis from indicated OTCs treated with either vehicle (PBS) or 50 ng/ml exogenous IL-1ra. Cell proliferation was measured using PCNA and cyclin D1. Values below each band were derived as described in Fig. 3 C. (B) Specific knockdown of sIL-1ra in human fibroblasts. (left) Knockdown efficiency was monitored by qPCR and normalized with control ribosomal protein P0. Specificity of knockdown was assessed by the relative expression level of icIL-1ra. (right) Protein expression of sIL-1ra and icIL-1ra as determined by ELISA. (C) Reduced fibroblasts sIL-1ra increase epidermal proliferation. OTCs were constructed using KCTRL with either control (FCTRL) or sIL-1ra knockdown (FsIL-1ra) fibroblasts. H&E, hematoxylin and eosin staining. (top) Ki67, cell proliferation (white arrows); DAPI, nuclear staining. Bars, 40 microm. (bottom) Bars, 20 microm. (left) Mean numbers of proliferating cells were derived as described in . Broken lines denote epidermal-dermal junction. (right) Immunoblot analysis of keratinocytes and fibroblasts extracted from two independent indicated OTCs. Equal amounts of total protein (50 microg) were resolved, electrotransferred, and probed for the indicated proteins. Values below each band represent the mean fold differences in expression level with respect to KCTRL or FCTRL extracted from KCTRL/FCTRL OTC. **, P < 0.01; ***, P < 0.001. Data are mean +/- SD, n = 3.
###end p 36
###begin p 37
###xml 306 314 306 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 430 438 430 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 483 490 483 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 743 751 743 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 888 895 888 895 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 888 895 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 916 920 916 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 916 920 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 922 930 922 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 172 177 <span type="species:ncbi:9606">human</span>
To strengthen these results, we examined the role of sIL-1ra on epidermal proliferation using RNA interference. An siRNA designed to target sIL-1ra was introduced into the human primary fibroblasts. qPCR and ELISA analyses revealed >95% reduction in sIL-1ra mRNA and protein in the transduced fibroblasts (Fig. 5 B). The knockdown showed high specificity for the targeted sIL-1ra mRNA as the level of icIL-1ra mRNA was unchanged (Fig. 5 B, left). The sIL-1ra knockdown fibroblasts (FsIL-1ra) were used in OTC. Consistent with the aforementioned results, reducing the sIL-1ra production in fibroblasts resulted in increased keratinocyte proliferation as indicated by the large increase in Ki67-positive cells and cyclin D1 and PCNA expression (Fig. 5 C, left and middle). This marked increase in epidermal cell proliferation is accompanied by enhanced activation of TAK1 and c-Jun in the FsIL-1ra when compared with FCTRL (Fig. 5 C, right).
###end p 37
###begin p 38
###xml 222 226 222 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 231 238 231 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 231 238 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 240 248 240 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table II</xref>
###xml 282 289 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 458 465 454 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 458 465 454 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 481 485 477 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 481 485 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 600 619 596 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Steude et al., 2002</xref>
###xml 621 640 617 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Florin et al., 2005</xref>
###xml 680 684 676 680 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 680 684 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 690 704 686 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 690 704 686 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 771 785 760 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 771 785 760 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
To provide further evidence that reduced sIL-1ra in fibroblasts results in the increased expression of mitogenic factors, protein arrays were used to compare conditioned media from OTCs using WT keratinocytes with either FCTRL or FsIL-1ra (Table II). In addition to those listed in Table I, the expression of two additional factors, chemokine ligand 1 (CXCL1)/growth-related oncogene-alpha and stromal-derived growth factor-1 (SDF-1), were increased in OTC FsIL-1ra compared with FCTRL. The expression of CXCL1 and SDF-1 is c-Jun dependent, and their expression increased keratinocyte proliferation (Steude et al., 2002; Florin et al., 2005). Similarly, when comparing OTCs with FCTRL and FPPARbeta/delta, there was a trend for higher CXCL1 and SDF-1 expression in OTCs FPPARbeta/delta, although the fold increase was not significant (unpublished data).
###end p 38
###begin p 39
###xml 57 63 57 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL1ra</sub>
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL1ra</sub></italic>
###xml 79 83 79 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
Relative fold change of protein expression in OTCs with FsIL1ra compared with FCTRL
###end p 39
###begin p 40
GRO-alpha, growth-related oncogene-alpha.
###end p 40
###begin p 41
###xml 210 214 210 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 216 220 216 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 335 336 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
The intensities of signals were quantified by densitometry. Positive control included in the array blot was used to normalize and compare the results from different membranes. Values obtained from the control KCTRL/FCTRL OTC were arbitrarily assigned a value of 1. Values represent the mean fold increase as compared with control OTC (n = 3).
###end p 41
###begin p 42
ChIP was performed on these genes using phospho-c-Jun antibody.
###end p 42
###begin p 43
P < 0.01.
###end p 43
###begin p 44
P < 0.1.
###end p 44
###begin p 45
###xml 137 141 137 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 143 147 143 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 153 157 153 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 159 166 159 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 287 294 287 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 287 294 287 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 310 314 310 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 310 314 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 316 322 316 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
###xml 431 437 431 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
###xml 540 554 540 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 540 554 540 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
Finally, we also performed ChIP using phospho-c-Jun antibodies on the KGF, GMCSF, and IL-6 gene promoters in fibroblasts extracted from KCTRL/FCTRL and KCTRL/FsIL-1ra OTCs. The sequences spanning the AP-1-binding site were significantly enriched in the immunoprecipitates obtained from FsIL-1ra compared with FCTRL (Fig. 6, left). This was further confirmed by qPCR normalized to chromatin before immunoprecipitation, i.e., input (Fig. 6, right). Altogether, we concluded that reduced sIL-1ra production in the fibroblasts, as observed in FPPARbeta/delta, had a pronounced mitogenic effect on the epidermis.
###end p 45
###begin p 46
###xml 85 92 85 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 85 92 85 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Increased c-Jun binding to AP-1 site of human KGF, GMCSF, and IL-6 gene promoter in F<italic><sub>sIL-1ra</sub></italic>.</bold>
###xml 344 348 344 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 354 361 354 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 392 396 392 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 392 396 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 404 411 404 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-1ra</sub>
###xml 404 411 404 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>sIL-1ra</sub></italic>
###xml 660 664 660 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 660 664 660 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 683 687 683 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 123 128 <span type="species:ncbi:9606">human</span>
Increased c-Jun binding to AP-1 site of human KGF, GMCSF, and IL-6 gene promoter in FsIL-1ra. ChIP of AP-1-binding site of human KGF (top), GMCSF (middle), and IL-6 (bottom) genes using phospho-c-Jun antibodies. The gene sequence spanning the AP-1 site and a random control sequence were analyzed by PCR in the immunoprecipitated chromatin of FCTRL and FsIL-1ra fibroblasts extracted from K/FCTRL and K/FsIL-1ra OTC, respectively. Preimmune serum was used as a control. qPCR was performed on immunoprecipitates of phospho-c-Jun antibodies and normalized to input (chromatin before immunoprecipitation). Results are represented in fold change as compared with FCTRL extracted from K/FCTRL OTC. M, 100 bp DNA ladder.
###end p 46
###begin title 47
###xml 18 22 <span type="species:ncbi:10090">mice</span>
PPARbeta/delta-KO mice show reduced sIL-1ra expression during early wound healing
###end title 47
###begin p 48
###xml 278 293 261 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7, A and B</xref>
###xml 533 541 516 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 649 665 632 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Tan et al., 2001</xref>
###xml 771 779 754 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 926 934 909 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 1481 1489 1464 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 D</xref>
###xml 1874 1882 1850 1858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 E</xref>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 996 1000 <span type="species:ncbi:10090">mice</span>
###xml 1277 1281 <span type="species:ncbi:10090">mice</span>
###xml 1587 1592 <span type="species:ncbi:10090">mouse</span>
###xml 1715 1720 <span type="species:ncbi:10090">mouse</span>
###xml 1987 1991 <span type="species:ncbi:10090">mice</span>
Next, we evaluated the relevance of our findings during mouse skin wound healing, an in vivo model that involves the IL-1alpha/beta pathway. We first showed that activated PPARbeta/delta increased the IL-1beta-induced sIL-1ra expression in WT but not in KO primary fibroblasts (Fig. 7, A and B). Next, we examined the expression of IL-1ra in skin wound biopsies collected during early wound healing. qPCR analysis of early wound biopsies (days 1-3) showed a significantly lower sIL-1ra expression in KO tissue when compared with WT (Fig. 7 C), which is consistent with the enhanced cell proliferation previously reported during early wound healing (Tan et al., 2001). Notably, this difference in sIL-1ra expression was no longer detected in later wound biopsy specimens (Fig. 7 C, day 7). The analysis of wound fluids collected from day 2 and 3 wound beds showed reduced sIL-1ra protein in KO mice when compared with WT mice (Fig. 7 C). The expression of icIL-1ra was unchanged between WT and KO mice (unpublished data). Because keratinocytes only produced icIL-1ra, the change in sIL-1ra expression was attributed to the fibroblasts, a hypothesis that was verified by qPCR analysis of laser microdissected epithelium and dermis sections from day 4 wound biopsies of WT and KO mice (Fig. S5 B). Consistent with our aforementioned results, wound KO dermis had reduced sIL-1ra expression and concomitantly increased levels of IL-6, GMCSF, and KGF when compared with wound WT dermis (Fig. 7 D). These results confirmed that the expression of sIL-1ra was also modulated by PPARbeta/delta in mouse fibroblasts. We next examined the effect of topical application of exogenous IL-1ra on the expression of IL-6, GMCSF, and mouse chemokine ligand 1 (KC; also known as CXCL1) in early wound biopsies. As expected, exogenous IL-1ra reduced IL-6, GMCSF, and KC expression in KO wounds (Fig. 7 E). In summary, in vivo wound biopsy and fluid analyses revealed lower sIL-1ra mRNA and protein in the KO mice. Our results showed that PPARbeta/delta-deficient fibroblasts had reduced sIL-1ra expression compared with WT cells and that this reduced sIL-1ra production increased epidermal proliferation.
###end p 48
###begin p 49
###xml 0 83 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Regulation of IL-1&#946; signaling via PPAR&#946;/&#948; during wound repair in KO mice.</bold>
###xml 544 545 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 558 559 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 608 609 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 815 816 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 830 831 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1236 1237 1210 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 1108 1112 <span type="species:ncbi:10090">mice</span>
Regulation of IL-1beta signaling via PPARbeta/delta during wound repair in KO mice. (A and B) Expression level of sIL-1ra (A) and icIL-1ra (B) in WT and KO fibroblasts. WT and KO primary fibroblasts were treated with PPARbeta/delta ligand (100 nM GW501516 [GW]) and/or 10 ng/ml IL-1beta. The mRNA (left) and protein (right) expression levels were measured by qPCR and ELISA, respectively. (C) Expression level of sIL-1ra in early wound biopsies of KO mice. Wound fluids and biopsies were collected at the indicated day post-wounding (days 1-3, n = 7; day 7, n = 4). Unwounded skin was used as control (ctrl; n = 4). sIL-1ra mRNA and protein levels were determined by qPCR and ELISA, respectively. (D) Expression of sIL-1ra, icIL-1ra, KGF, IL-6, and GMCSF mRNAs from laser capture microdissected (LCM) dermis of WT (n = 3) and KO (n = 4) wound biopsies. Indicated mitogenic factor mRNA levels were analyzed by qPCR and normalized to control ribosomal protein P0. (E) Expression levels of indicated factor mRNAs in vehicle (veh; carboxymethylcellulose)- and IL-1ra-treated (3 x 2.5 microg) wounds of KO and WT mice as compared with corresponding unwounded (control) skin. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Data are mean +/- SEM, n = 4.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 1137 1143 1123 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8</xref>
Wound healing is a complex process that consists of a cascade of overlapping events, including inflammation reepithelialization and remodeling, directed at the restoration of the epidermal barrier. Throughout the whole healing process, interaction between different cell types provides coordination of the individual events, allowing for a temporal and spatial control. Reepithelialization is accomplished by increased keratinocyte proliferation and guided migration over the granulation tissue. Such processes require ordered changes in keratinocyte behavior that is dictated by the interplay of keratinocytes with dermal fibroblasts, i.e., epithelial-mesenchymal communication. The results presented in this study characterize a novel unsuspected role of PPARbeta/delta in fibroblasts, which ensure a balanced functional interaction between dermis and epidermis. We show that keratinocyte proliferation is controlled by the dermal fibroblasts that produce AP-1-dependent mitogenic factors under the control of the IL-1/TAK1 signaling cascade whose activity level is modulated by PPARbeta/delta via a direct control sIL-1ra production (Fig. 8).
###end p 51
###begin p 52
###xml 0 59 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The autonomous and nonautonomous actions of PPAR&#946;/&#948;.</bold>
###xml 211 230 197 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Di Poi et al., 2002</xref>
###xml 232 248 218 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Tan et al., 2007</xref>
The autonomous and nonautonomous actions of PPARbeta/delta. PPARbeta/delta confers antiapoptotic properties to keratinocytes and potentiates their migration via AKT1 and Rho GTPases in a cell-autonomous manner (Di Poi et al., 2002; Tan et al., 2007). PPARbeta/delta also influences keratinocyte differentiation in a yet unknown mechanism. PPARbeta/delta regulates epidermal proliferation in a nonautonomous fashion via a paracrine mechanism. IL-1 constitutively produced by the adjacent keratinocytes activates c-Jun, an obligate partner of AP-1 transcription factor via TAK1, and consequently increases the production of several mitogenic factors. The expression of PPARbeta/delta in the underlying fibroblasts attenuates this IL-1 signaling via the production of sIL-1ra. sIL-1ra has little affinity for IL-1R2, which is highly expressed in keratinocytes. Thus, sIL-1ra acts in an autocrine fashion onto the fibroblasts, which expressed the predominant functional IL-1R1. The binding of sIL-1ra to IL-1R1 modulates the IL-1-mediated signaling events and consequently decreases the production of several AP-1-mediated mitogenic factors. The mitogenic factors exert a reduced paracrine effect on the epithelial proliferation via their cognate receptors (R). Therefore, PPARbeta/delta in the fibroblasts plays an important homeostatic role in maintaining epidermal homeostasis, the absence of PPARbeta/delta resulting in significant epidermal proliferation.
###end p 52
###begin p 53
###xml 433 451 433 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Cheng et al., 2005</xref>
###xml 767 773 753 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8</xref>
Epidermal homeostasis requires a continuous exchange of signals with the underlying dermal compartment. Fibroblasts are a major cell type in the dermis, and their function in regulating extracellular matrix deposition and growth factor expression determines the differentiation states of the epidermis. Previous studies have showed that gene expression changes in the dermal fibroblasts significantly influence epithelial cell fate (Cheng et al., 2005). In the presence of IL-1-producing keratinocytes, PPARbeta/delta was the predominant PPAR isotype in fibroblasts. Interestingly, PPARbeta/delta directly increased the expression of sIL-1ra in the fibroblasts that acted in an autocrine manner to modulate the expression of several IL-1-dependent mitogenic factors (Fig. 8). This autocrine action is possible because IL-1R1 is the predominant IL-1R subtype in fibroblasts, whereas keratinocytes exhibit IL-1R2 that has very low affinity for sIL-1ra and protects them from an exacerbated autocrine action of the IL-1alpha/beta that they constitutively produce. This study underscores the fact that PPARbeta/delta in the dermal fibroblasts fulfils a homeostatic role during epidermal formation, balancing cell proliferation via a control on IL-1alpha/beta signaling.
###end p 53
###begin p 54
###xml 155 171 148 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Kim et al., 2004</xref>
###xml 415 431 404 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Kim et al., 2005</xref>
###xml 624 644 605 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Wang and Smart, 1999</xref>
###xml 646 668 627 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Cataisson et al., 2003</xref>
###xml 758 780 735 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Cataisson et al., 2003</xref>
###xml 977 998 954 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Michalik et al., 2001</xref>
###xml 1000 1016 977 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Tan et al., 2001</xref>
###xml 1142 1158 1119 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Kim et al., 2005</xref>
###xml 1275 1296 1252 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Michalik et al., 2001</xref>
###xml 2038 2054 2001 2017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Tan et al., 2001</xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 556 561 <span type="species:ncbi:9606">human</span>
###xml 603 608 <span type="species:ncbi:10090">mouse</span>
###xml 700 705 <span type="species:ncbi:10090">mouse</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
###xml 1136 1140 <span type="species:ncbi:10090">mice</span>
###xml 1269 1273 <span type="species:ncbi:10090">mice</span>
###xml 1835 1839 <span type="species:ncbi:10090">mice</span>
###xml 1985 1989 <span type="species:ncbi:10090">mice</span>
It was reported that the enhanced TPA-induced hyperplasia in KO mice was a result of reduced ubiquitin C, whose expression is regulated by PPARbeta/delta (Kim et al., 2004). The impaired ubiquitin-dependent proteosome-mediated protein turnover in KO mice resulted in a higher PKCalpha level, increased Raf1, and MAPK/extracellular signal-regulated kinase activities, which led to an increase in cell proliferation (Kim et al., 2005). Other studies have shown that PKCalpha overexpression in two different models did not affect the proliferation of primary human keratinocytes and of PKCalpha transgenic mouse keratinocytes (Wang and Smart, 1999; Cataisson et al., 2003). In fact, PKCalpha transgenic mouse keratinocytes treated with TPA underwent apoptosis (Cataisson et al., 2003). This is in apparent discrepancy with the delayed wound healing kinetics observed in KO mice. Enhanced keratinocyte proliferation was also observed in many situations not involving TPA exposure (Michalik et al., 2001; Tan et al., 2001). Furthermore, no difference was observed in phosphorylated MEK-1/2 and ERK-1/2 expression between untreated KO and WT mice (Kim et al., 2005). This raises the question of how epidermal hyperproliferation occurs at wound edges early after injury of KO mice (Michalik et al., 2001). These observations point to a complex role of PPARbeta/delta in cell proliferation. Our results showing that PPARbeta/delta deficiency in fibroblasts increases their mitogenic effect on epithelial cells unveil part of this complexity. The underlying mechanism involves reduced sIL-1ra production by the fibroblasts, allowing a stronger IL-1 signaling, resulting in increased TAK1 activity with a consequent rise in mitogenic growth factor production. The in vivo relevance of this mechanism was observed during early wound repair in KO mice with reduced sIL-1ra in early but not late wound biopsies. This pattern is consistent with the early epidermal hyperproliferation reported in KO mice during the inflammatory phase of wound healing (Tan et al., 2001).
###end p 54
###begin p 55
###xml 111 127 104 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Tan et al., 2001</xref>
###xml 129 145 122 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Man et al., 2008</xref>
###xml 314 333 296 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Di Poi et al., 2002</xref>
###xml 424 448 406 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Letavernier et al., 2005</xref>
###xml 489 507 471 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Schug et al., 2007</xref>
###xml 742 761 714 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Beanes et al., 2003</xref>
###xml 910 926 872 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Tan et al., 2004</xref>
###xml 1081 1095 1043 1050 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 1081 1095 1043 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 1465 1490 1401 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Mukhopadhyay et al., 1997</xref>
###xml 1492 1510 1428 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Green et al., 2001</xref>
###xml 1597 1613 1533 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Ong et al., 2007</xref>
###xml 1725 1746 1661 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Michalik et al., 2001</xref>
###xml 129 132 <span type="species:ncbi:9606">Man</span>
###xml 386 391 <span type="species:ncbi:10090">mouse</span>
###xml 457 462 <span type="species:ncbi:9606">human</span>
###xml 1719 1723 <span type="species:ncbi:10090">mice</span>
This study and earlier studies suggest different roles of PPARbeta/delta in the dermis and adjacent epidermis (Tan et al., 2001; Man et al., 2008). The activation of PPARbeta/delta conferred antiapoptotic properties to keratinocytes, which are mediated in part by the increased activation of the PKBalpha pathway (Di Poi et al., 2002). This antiapoptotic role was similarly observed in mouse tubular renal epithelial cells (Letavernier et al., 2005) and in human keratinocyte HaCaT cells (Schug et al., 2007). Our data now clearly show that PPARbeta/delta signaling in fibroblasts has a pronounced effect on the growth potential of adjacent epithelia. Such differential roles were previously observed for TGF-beta1 signaling in wound repair (Beanes et al., 2003). Interestingly, an in vivo cross talk between TGF-beta1/Smad3 and PPARbeta/delta signaling in keratinocytes during wound repair has been reported (Tan et al., 2004). The development of a vascular supply is important for wound healing. Interestingly, we also observed a reduced expression of VEGF and PIGF in OTC with FPPARbeta/delta. Although it is tempting to speculate that both VEGF and PIGF may be target genes of PPARbeta/delta, their regulation are complex and context dependent, involving numerous factors such as pVHL (von Hippel-Lindau tumor suppressor), Sp-1, NF-kappaB (nuclear factor kappa light chain enhancer of activated B cells), hypoxia-inducible factor alpha, and AP-1, among others (Mukhopadhyay et al., 1997; Green et al., 2001). Importantly, epithelial-mesenchymal interactions can also modulate VEGF expression (Ong et al., 2007). During wound repair, an impaired angiogenesis is in line with the delayed wound healing observed in KO mice (Michalik et al., 2001).
###end p 55
###begin p 56
###xml 439 457 439 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Lewis et al., 2006</xref>
###xml 617 635 610 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Gupta et al., 2000</xref>
###xml 637 655 630 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Barak et al., 2002</xref>
###xml 657 676 650 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Harman et al., 2004</xref>
###xml 777 791 770 777 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 777 791 770 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 826 831 <span type="species:ncbi:9606">human</span>
The tissue microenvironment plays a pivotal role in modulating gene expression and cellular behavior, including epithelial-mesenchymal communication. Likewise, the microenvironment milieu is constituted by factors produced and released by these various cell types as communication signals. Of interest, the activation of IL-1 signaling was reported to coerce the growth of tumors, whereas its repression by IL-1ra has an antitumor effect (Lewis et al., 2006). The role of PPARbeta/delta in tumorigenesis remains debatable because there is evidence that this PPAR isotype potentiates or attenuates epithelial cancers (Gupta et al., 2000; Barak et al., 2002; Harman et al., 2004). Although this question is not directly addressed in this study, our preliminary data showed that FPPARbeta/delta can increase the proliferation of human squamous carcinoma cells (unpublished data).
###end p 56
###begin title 57
Materials and methods
###end title 57
###begin title 58
Reagents
###end title 58
###begin p 59
###xml 455 459 <span type="species:ncbi:9925">goat</span>
###xml 465 470 <span type="species:ncbi:10090">mouse</span>
###xml 539 542 <span type="species:ncbi:10116">rat</span>
###xml 934 939 <span type="species:ncbi:9606">human</span>
The following antibodies and suppliers were used: anti-Ki67, antikeratin 10, anti-involucrin, antikeratin 6 (Novacastra), anti-PPARalpha, anti-PPARbeta/delta, and anti-PPARgamma (Millipore and Thermo Fisher Scientific); all cytokines and neutralizing antibodies against IL-1alpha, IL-1beta, KGF, IL-6, and GMCSF (PeproTech); anti-c-Jun, antiphospho(Ser63)-c-Jun, anti-TAK1, and antiphospho-TAK1 (Cell Signaling Technology); and Alexa Fluor 488-conjugated goat anti-mouse antibody (Invitrogen). Real-time reagent SYBR GreenER (Invitrogen), rat tail collagen type I (BD), and transfection reagent Superfect (QIAGEN) were used. All restriction enzymes and DNA/RNA modifying enzymes were obtained from Fermentas. Double-promoter lentivirus-based siRNA vector and pFIV Packaging kit (System Biosciences) was used. The PPARalpha, beta/delta, gamma Complete Transcription Factor Assay kit was obtained from Cayman Chemical. Primary neonatal human fibroblasts and keratinocytes were obtained from Invitrogen. GW501516 was obtained from Enzo Biochem, Inc. Otherwise, chemicals were obtained from Sigma-Aldrich.
###end p 59
###begin title 60
Total RNA isolation, reverse transcription PCR, and qPCR
###end title 60
###begin p 61
Total RNA was extracted from fresh tissues using Aurum total RNA kit (Bio-Rad Laboratories) following the supplier's protocol. 5 mug total RNA was reverse transcribed with oligo-dT primers using RevertAid H Minus M-MuLV (Fermentas). After reverse transcription, the RNAs were removed by RNase H digestion. qPCR was performed with platinum Taq polymerase and SYBR GreenER super mixes using a PCR machine (MiniOpticon; Bio-Rad Laboratories). Melt curve analysis was included to assure that only one PCR product was formed. Primers were designed to generate a PCR amplification product of 100-250 bp. Only primer pairs yielding unique amplification products without primer dimer formation were subsequently used for real-time PCR assays. Expression was related to the control gene ribosomal protein P0 (RPLP0), which did not change under any of the experimental conditions studied. The sequence of primers is available in . For each wound biopsies, 10 8-microm-thick tissues were microdissected and pooled. RNA was isolated from microdissected paraformaldehyde-fixed paraffin-embedded sections using RecoverAll Total Nucleic Acid Isolation kit (Applied Biosystems). 5 ng RNA was subjected to Full Spectrum Complete Transcriptome RNA Amplification kit (System Biosciences) prior to qPCR.
###end p 61
###begin title 62
Lentivirus-mediated knockdown of PPARbeta/delta and sIL-1ra
###end title 62
###begin p 63
###xml 25 30 <span type="species:ncbi:9606">human</span>
Two siRNAs targeting the human PPARbeta/delta, one against sIL-1ra and one unrelated control siRNA, were subcloned into the lentiviral-based siRNA vector pFIV-H1/U6-puro. The correct pFIV siRNA constructs were verified by sequencing using H1 primer. The sequence of the siRNAs was as given in Table S1. Transduction-ready pseudoviral particles (System Biosciences) were produced and harvested as described by the manufacturer. Transduced cells were enriched by puromycin selection for 1 wk. Western blot analysis, ELISA, or qPCR were used to assess the efficiency of knockdown.
###end p 63
###begin title 64
Transactivation assay
###end title 64
###begin p 65
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 558 563 <span type="species:ncbi:9606">Human</span>
An approximately4.4-kb (-1572 to -5980) promoter of the human sIL-1ra was PCR amplified from human genomic DNA using Pfu polymerase. The primer pairs used are given in Table S1. The resulting fragment was used for a second PCR amplification step introducing SacI and BglII sites that were used for subcloning into the pGL-3 Basic vector (Promega). Site-directed mutagenesis of the three putative PPREs (PPRE1 at -1038/-1050, PPRE2 at -1072/-1084, and PPRE3 at -4067/-4079) were achieved using QuikChange site-directed mutagenesis kit (Agilent Technologies). Human fibroblasts were routinely grown in medium 106 (Invitrogen). Fibroblasts were cotransfected with a luciferase reporter driven by the various sIL-1ra promoter constructs and pEF1-beta-galactosidase as a control of transfection efficiency using Superfect. After transfection, cells were incubated in the presence or absence of 500 nM PPARbeta/delta ligand GW501516 and IL-1beta for 24 h before lysis. Transfections with the positive control reporter pGL-3xPPRE-tk-Luc were included (provided by R.M. Evans, The Salk Institute for Biological Studies, University of California, San Diego, La Jolla, CA). Luciferase activity was measured using the luciferase assay (Promega) on a Microbeta Trilux (PerkinElmer). beta-Galactosidase activity was measured in the cell lysate by a standard assay using 2-nitrophenyl-betaD-galactopyranoside as a substrate.
###end p 65
###begin title 66
ChIP
###end title 66
###begin p 67
###xml 44 60 44 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Tan et al., 2004</xref>
###xml 169 174 <span type="species:ncbi:9606">human</span>
ChIP was performed as described previously (Tan et al., 2004) with minor modifications. In brief, epidermis from OTC was physically separated from the collagen-embedded human fibroblasts after 2.5 U/ml dispase treatment at 37degreesC for 20 min. The dermal equivalents were thoroughly washed with PBS. The collagen gel was cut into small pieces prior to digestion with 0.5% collagenase I at 37degreesC. The fibroblasts were retrieved and cross-linked with 1% formaldehyde for 15 min at 37degreesC prior to sonication in lysis buffer. Monoclonal anti-PPARbeta/delta antibody was used. The immunoprecipitates were reverse cross-linked for PCR by heating at 65degreesC for 6 h. The primer pairs used are shown in Table S1.
###end p 67
###begin title 68
OTC
###end title 68
###begin p 69
###xml 232 259 232 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Maas-Szabowski et al., 2000</xref>
###xml 592 593 592 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 848 849 838 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1698 1699 1656 1657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1846 1847 1798 1799 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 377 380 <span type="species:ncbi:10116">rat</span>
Primary human keratinocytes and fibroblasts were routinely maintained in defined keratinocyte medium (EpiLife; Invitrogen) and medium 106, respectively, as described by the manufacturer. OTCs were performed as previously described (Maas-Szabowski et al., 2000) in serum-free OTC medium with some modifications. 1 vol 10x HBSS containing phenol red was mixed with 8 vol 4 mg/ml rat tail type I collagen (BD). The acetic acid was neutralized with 1 N NaOH on ice. Fibroblasts were resuspended in 1 vol 1x HBSS and added dropwise to the neutralized collagen to achieve a final cell density of 105 cells/ml of collagen. 3 ml of this fibroblast/collagen mixture was dispensed into a 24-mm diameter Transwell culture insert (3-microm pore size; BD). The culture insert was placed in a 6-well Deep-Well Plate (BD) and allowed to gel in a 37degreesC, 5% CO2, 70% humidity incubator (Thermo Fisher Scientific). Glass rings (outer diameter, 20 mm; thickness, 1.2 mm; height, 12 mm) were centrally placed onto the collagen. The glass rings serve to compress the collagen and delimit the area for the seeding of keratinocytes. The fibroblast-embedded collagen was submerged and cultured in serum-free OTC medium overnight. The serum-free OTC contains basal medium, 3:1 (vol/vol) DME (low glucose), Ham's F-12 nutrient mixture, basal supplements 5 microg/ml insulin, 1 ng/ml epidermal growth factor, 0.4 microg/ml hydrocortisone, 100 nM adenine, 10 microM serine, 100 nM cholera toxin, 10 microM carnitine, 1 mg/ml fatty acid-free albumin, lipid supplements 0.05 mM ethanolamine, 1 microM isoproterenol, 1 microM alpha-tocopherol, and 50 microg/ml ascorbic acid. The following day, the medium was removed and 106 keratinocytes were seeded into the center of the glass ring. OTC medium was added, and the setup was once again incubated at 37degreesC with 5% CO2 for 24 h to allow the keratinocytes to attach. The next day, the glass ring was removed, and culture was maintained at air liquid interface. Medium was changed every 3 d for a total of 2 wk. Neutralizing antibodies (each at 400 ng/ml) were freshly supplemented at every change of medium throughout the 2-wk culture period.
###end p 69
###begin title 70
Immunofluorescence
###end title 70
###begin p 71
###xml 438 459 416 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Michalik et al., 2001</xref>
###xml 500 504 <span type="species:ncbi:9925">goat</span>
###xml 510 515 <span type="species:ncbi:10090">mouse</span>
OTCs were fixed with 4% paraformaldehyde in PBS for 2 h at 25degreesC. The fixed OTCs were washed twice with PBS and embedded in Tissue-Tek OCT compound medium (Sakura) overnight at 4degreesC. The skin cultures were subsequently frozen at -70degreesC for cryosectioning. 10-microm cryostat tissue sections were mounted on SuperFrost Plus slides (Menzel-Glaser). The sections were processed for immunofluorescence as described previously (Michalik et al., 2001) except that Alexa Fluor 488-conjugated goat anti-mouse secondary antibody was used. The apoptotic keratinocytes were detected using the TUNEL assay according to the manufacturer's protocol (Roche). As positive control for TUNEL assay, the section was pretreated with DNase I. The slides were mounted with antifade reagent (ProLong Gold; Invitrogen) with DAPI. Images were taken with an inverted microscope (ECLIPSE TE2000-U; Nikon) using a Plan Fluor 20x/0.45 objective (Nikon), Retiga EXi FAST cooled mono 12-bit camera (QImaging), and Image-Pro Plus software (Media Cybernetics).
###end p 71
###begin title 72
Wounding experiment
###end title 72
###begin p 73
###xml 72 93 72 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Michalik et al., 2001</xref>
###xml 161 177 161 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Tan et al., 2004</xref>
###xml 342 358 342 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Tan et al., 2005</xref>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Wounding of the mice dorsal skin was performed as previously described (Michalik et al., 2001). Wound biopsies and fluids were isolated as previously described (Tan et al., 2004) and were immediately snap frozen in liquid nitrogen for further analysis. Topical application of exogenous IL-1ra treatment was performed as previously described (Tan et al., 2005) except that three applications of 2.5 microg recombinant IL-1ra were added over 3 d.
###end p 73
###begin title 74
Measurement of cytokines by ELISA
###end title 74
###begin p 75
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
The concentration of sIL-1ra and icIL-1ra measured using sandwich ELISA (R&D Systems). In brief, 2 x 105 cells were cultured in a 35-mm culture dish with 750 microl of medium and subjected to the indicated treatments. After 24 h, the media were harvested and treated with the addition of Complete protease inhibitors (Roche). The level of sIL-1ra was measured in culture supernatants accordingly to the manufacturer's instruction. To measure icIL-1ra, the cells were washed thoroughly, harvested by treatment with trypsin, and collected by centrifugation in fresh serum-free culture medium. The cell pellet was resuspended in 750 microl of medium, disrupted by sonication, and the debris was removed by centrifugation. The concentration of icIL-ra in the supernatant was measured by ELISA.
###end p 75
###begin title 76
Protein arrays
###end title 76
###begin p 77
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Inflammation Antibody Array 3 and Growth Factor Antibody Array membranes (RayBiotech) were processed according to the manufacturer's protocol. Protein spots were detected by chemiluminescence. Signal intensities were quantified using ImageJ (National Institutes of Health) analysis software and were normalized with the mean intensity of the positive controls on each membrane.
###end p 77
###begin title 78
Western blot analysis
###end title 78
###begin p 79
###xml 242 243 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 244 245 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 248 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Epidermis was physically separated from OTC after a 20-min treatment with dispase. Fibroblasts embedded in collagen were isolated after collagenase treatment. For Western blotting, protein extracts were made in ice-cold lysis buffer (20 mM Na2H2PO4, 250 mM NaCl, 1% Triton X-100, and 0.1% SDS). Equal amounts of protein extracts (50 microg) were resolved by SDS-PAGE and electrotransferred onto PVDF membranes. Membranes were processed as described by the manufacturer of antibodies, and proteins were detected by chemiluminescence (Millipore). Coomassie blue-stained membrane or tubulin was used to check for equal loading and transfer.
###end p 79
###begin title 80
Online supplemental material
###end title 80
###begin p 81
###xml 143 147 136 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTRL</sub>
###xml 143 147 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>CTRL</sub></italic>
###xml 152 166 145 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 152 166 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 639 653 611 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#946;/&#948;</sub>
###xml 639 653 611 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>PPAR&#946;/&#948;</sub></italic>
###xml 212 217 <span type="species:ncbi:9606">human</span>
###xml 485 490 <span type="species:ncbi:9606">human</span>
Fig. S1 shows immunofluorescence staining of 2-wk old OTCs. Fig. S2 shows immunoblot analysis of IL-1beta and TNF-alpha activation of TAK1 in FCTRL or FPPARbeta/delta fibroblasts and ChIP of AP-1-binding site of human KGF and GMCSF genes using phospho-c-Jun antibodies. Fig. S3 shows immunofluorescence staining of 2-wk-old OTCs treated with neutralizing antibodies against IL-1alpha and beta or against KGF, GMCSF, and IL-6. Fig. S4 shows the alignment of the two functional PPREs in human sIL-1ra promoter to consensus PPRE. Fig. S5 shows immunofluorescence staining of 2-wk old OTCs derived using PPARbeta/delta-deficient fibroblasts (FPPARbeta/delta) treated with either vehicle or exogenous IL-1ra. Table S1 shows the sequence of primers used in this study. Online supplemental material is available at .
###end p 81
###begin title 82
Supplementary Material
###end title 82
###begin title 83
[Supplemental Material Index]
###end title 83
###begin p 84
We thank Dr. Samuel Ko and Anna Teo (Carl Zeiss, Inc.) for their expertise in laser capture microdissection and R.M. Evans for the positive PPRE reporter construct.
###end p 84
###begin p 85
This work was supported by grants from the Academic Research Fund, the Ministry of Education (ARC8/06 to N.S. Tan), Supplementary Equipment Purchase (RG127/05 to N.S. Tan), and the Swiss National Science Foundation (W. Wahli).
###end p 85
###begin article-title 86
Interleukin-1 receptor antagonist: role in biology.
###end article-title 86
###begin article-title 87
Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome.
###end article-title 87
###begin article-title 88
Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.
###end article-title 88
###begin article-title 89
Skin repair and scar formation: the central role of TGF-beta.
###end article-title 89
###begin article-title 90
The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation.
###end article-title 90
###begin article-title 91
Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways.
###end article-title 91
###begin article-title 92
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.
###end article-title 92
###begin article-title 93
Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway.
###end article-title 93
###begin article-title 94
Identification of novel AP-1 target genes in fibroblasts regulated during cutaneous wound healing.
###end article-title 94
###begin article-title 95
Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts.
###end article-title 95
###begin article-title 96
Epithelial-mesenchymal interactions regulate keratinocyte growth and differentiation in vitro.
###end article-title 96
###begin article-title 97
The Keratinocyte Handbook.
###end article-title 97
###begin article-title 98
Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1.
###end article-title 98
###begin article-title 99
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease.
###end article-title 99
###begin article-title 100
Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.
###end article-title 100
###begin article-title 101
Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.
###end article-title 101
###begin article-title 102
###xml 20 25 <span type="species:ncbi:9606">human</span>
Cytokine-stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26).
###end article-title 102
###begin article-title 103
In vivo activation of PPAR target genes by RXR homodimers.
###end article-title 103
###begin article-title 104
Roles of PPARs in health and disease.
###end article-title 104
###begin article-title 105
Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis.
###end article-title 105
###begin article-title 106
Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity.
###end article-title 106
###begin article-title 107
Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
###end article-title 107
###begin article-title 108
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment.
###end article-title 108
###begin article-title 109
Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts.
###end article-title 109
###begin article-title 110
Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation.
###end article-title 110
###begin article-title 111
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice.
###end article-title 111
###begin article-title 112
The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.
###end article-title 112
###begin article-title 113
A unified nomenclature system for nuclear receptor superfamily.
###end article-title 113
###begin article-title 114
Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion.
###end article-title 114
###begin article-title 115
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).
###end article-title 115
###begin article-title 116
NUBIScan, an in silico approach for prediction of nuclear receptor response elements.
###end article-title 116
###begin article-title 117
Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation.
###end article-title 117
###begin article-title 118
Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes.
###end article-title 118
###begin article-title 119
Cytokine networks in the skin.
###end article-title 119
###begin article-title 120
Opposing effects of retinoic Acid on cell growth result from alternate activation of two different nuclear receptors.
###end article-title 120
###begin article-title 121
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
###end article-title 121
###begin article-title 122
###xml 30 35 <span type="species:ncbi:9606">human</span>
LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements.
###end article-title 122
###begin article-title 123
Dynamic of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture.
###end article-title 123
###begin article-title 124
###xml 139 144 <span type="species:ncbi:9606">human</span>
Interleukin-1-stimulated secretion of interleukin-8 and growth-related oncogene-alpha demonstrates greatly enhanced keratinocyte growth in human raft cultured epidermis.
###end article-title 124
###begin article-title 125
c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin.
###end article-title 125
###begin article-title 126
Critical roles of PPAR beta/delta in keratinocyte response to inflammation.
###end article-title 126
###begin article-title 127
Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression.
###end article-title 127
###begin article-title 128
Genetic- or transforming growth factor-beta1-induced changes in epidermal peroxisome proliferator-activated receptor beta/delta expression dictate wound repair kinetics.
###end article-title 128
###begin article-title 129
The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration.
###end article-title 129
###begin article-title 130
###xml 61 76 <span type="species:ncbi:10090">transgenic mice</span>
Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion.
###end article-title 130
###begin article-title 131
Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macrophages.
###end article-title 131
###begin article-title 132
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
IL-18 induces a marked gene expression profile change and increased Ccl1 (I-309) production in mouse mucosal mast cell homologs.
###end article-title 132
###begin p 133
Abbreviations used in this paper: AP-1, activation protein-1; ChIP, chromatin immunoprecipitation; EMSA, electrophoretic mobility shift assay; GMCSF, granulocyte macrophage colony-stimulating factor; icIL-1ra, intracellular IL-1ra; IL, interleukin; IL-1R, IL-1 receptor; IL-1ra, IL-1R antagonist; KGF, keratinocyte growth factor; OTC, organotypic skin culture; PCNA, proliferating cell nuclear antigen; PIGF, placental growth factor; PPAR, peroxisome proliferator-activated receptor; PPRE, peroxisome proliferator response elements; qPCR, quantitative real-time PCR; SDF-1, stromal-derived growth factor-1; sIL-1ra, secreted IL-1ra; TAK1, TGF-activated kinase 1; WT, wild type.
###end p 133

